Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pediatric inflammatory bowel disease.

Helen M Pappa1, Gaith Semrin, Thomas R Walker

  • 1Center for Inflammatory Bowel Disease, Division of Gastroenterology and Nutrition, Department of Medicine, Children's Hospital Boston, Massachusetts 02115, USA.

Current Opinion in Gastroenterology
|February 11, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bone marrow adiposity in pediatric Crohn's disease.

Bone·2022
Same author

Augmented ustekinumab dosing is needed to achieve clinical response in patients with anti-TNF refractory pediatric Crohn's disease: a retrospective chart review.

F1000Research·2021
Same author

DIGEST: Developing innovative gastroenterology specialty training.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2020
Same author

Concordance between gene expression in peripheral whole blood and colonic tissue in children with inflammatory bowel disease.

PloS one·2019
Same author

Differences in DNA Methylation and Functional Expression in Lactase Persistent and Non-persistent Individuals.

Scientific reports·2018
Same author

Risk factors for low bone mineral density in pediatric inflammatory bowel disease: the positive role of physical activity.

European journal of gastroenterology & hepatology·2018

Early-onset inflammatory bowel disease (IBD) is increasing in children. Recent advances in genetics, diagnostics like MRI, and novel therapies offer new hope for managing pediatric IBD and improving outcomes.

Area of Science:

  • Pediatric gastroenterology
  • Genetics of IBD
  • Inflammatory bowel disease research

Background:

  • Rising prevalence of early-onset inflammatory bowel disease (IBD) in children and adolescents.
  • Significant advancements in adult IBD diagnostics and therapeutics.
  • Growing understanding of genetic factors influencing IBD susceptibility.

Purpose of the Study:

  • To review recent literature on pediatric inflammatory bowel disease.
  • To highlight advances in genetics, diagnostics, and therapy for pediatric IBD.
  • To discuss the evolving role of genetics and new treatments in managing pediatric IBD.

Main Methods:

  • Review of recent scientific literature on pediatric inflammatory bowel disease.
  • Analysis of studies on genetic susceptibility and genotype-phenotype correlations.

Related Experiment Videos

  • Evaluation of research on noninvasive diagnostic modalities (MRI, fecal lactoferrin).
  • Assessment of empirical use and systematic study of novel therapeutic agents in pediatric IBD.
  • Review of studies on surgical outcomes in pediatric IBD.

    • Main Results:

    • Strong evidence for genetic susceptibility to IBD, linking genotype to phenotype.
    • Exploration of noninvasive diagnostics like MRI and fecal lactoferrin in pediatric IBD.
    • Empirical administration and initial systematic studies of new therapeutic agents in children.
    • Revised understanding of surgical outcomes in pediatric inflammatory bowel disease.

    Conclusions:

    • Genetic testing shows evolving potential for predicting susceptibility and guiding therapy in pediatric IBD.
    • Inclusion of pediatric patients in clinical trials for new IBD therapies is crucial.
    • Future research aims to alter the natural history of early-onset IBD, reduce recurrence, and minimize surgery.